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Abstract
Introduction: Transcutaneous CO2 (PtCO2) is a continuous and non-invasive measure recommended by scientific
societies in the management of respiratory distress. The objective of this study is to evaluate the correlation between
PtCO2 and blood pressure of CO2 (PaCO2) by blood gas analysis in emergency patients with dyspnoea and to
determine the factors that interfere in this correlation.
Methods: From January to June 2014, all patients admitted to resuscitation room of the emergency department
targeted for arterial blood gases were included prospectively. A sensor measuring the PtCO2 was attached to the ear
lobe of the patient before the gas analysis. Anamnesis, clinical and laboratory parameters were identified.
Results: 90 patients with dyspnoea were included (with 104 pairs of measurements), the median age was 79 years
[69-85]. The correlation between PtCO2 and PaCO2 was R2= 0.83 (p<0.001) but became lower for values of
PaCO2 >60 mm Hg. The mean bias (±SD) between the two methods of measurement (Bland-Altman analysis) was
-1.4 mm Hg (±7.7) with limits of agreement of -16.4 to 13.7 mm Hg. In univariate analysis, PaO2 interfered in this
correlation. After multivariate analysis, the temperature (OR = 3.01, 95% CI = 1.16-7.09) and the PaO2 (OR = 1.22, 95%
CI = 1.02-1.47) were found to be significant.
Conclusions: In patients admitted in emergency unit for acute respiratory failure, there is a significant correlation
between PaCO2 and PtCO2, mainly for values below 60 mm Hg. The two limiting factors of use are hyperthermia and
users training.
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Introduction
In patients with respiratory failure admitted to resusci-
tation room (RR), the monitoring of arterial blood gases
is crucial for diagnosis and therapeutic guidance [1].
The gold standard remains the analysis of arterial blood
gases. This implies an arterial puncture that it is inva-
sive, time consuming and giving only punctual results
[2,3]. In addition, pending the results of blood gas analysis
does not allow for real-time adaptation of oxygen ther-
apy and/or mechanical ventilation. Oxygen saturation by
pulse oxymetry (SpO2) is widely used as a surrogate of
arterial oxygen saturation (SaO2) [4]. In mechanically ven-
tilated patients, end tidal CO2 (EtCO2) allows an indirect
reliable continuous assessment of arterial PCO2. In non-
ventilated patients, assessment of EtCO2 is more complex,
less accurate and often impossible. The transcutaneous
monitoring of the carbon dioxide (PtCO2) could repre-
sent a good alternative for immediate and continuous
assessment of PCO2 in RR, especially in non-ventilated
patients. The transcutaneous continuous monitoring of
the carbon dioxide has been recently recommended [5,6].
In the specific setting of RR, PtCO2 has been poorly
studied. Numerous studies in infants [7,8] and adults
[9-11] have found a good correlation between PaCO2 and
PtCO2. The main objective of this study was to investigate
the relationship between measures of PtCO2 and PaCO2
in resuscitation room patients admitted. The secondary
objective was to determine the factors that may disrupt
the link between these two parameters.
Patients andmethods
Setting and study population
This single-center prospective observational study was
conducted from January to June 2014 at the emergency
department (ED) of Nîmes University Hospital. Accord-
ing to the French Law (Law 88-1138 relative to Biomedical
Research of 20 December 1988 modified on 9 August
2004), this non-interventional study did not require
approval by an ethics committee nor informed signed con-
sent from patients. It was reviewed and approved by our
Institutional Review Board (number: 13/06-02). More-
over, the present study was declared to and approved by
the national commission for data processing and civil lib-
erties. All patients provided written informed consent.
All adult patients oriented in the RR and with an arte-
rial blood gas during laboratory tests were likely to be
included in the study. Exclusion criteria were the real-
ization of venous blood gases and non-compliance of
the study protocol (incorrect installation of the sensor or
signal abnormality of the monitor or backup).
The PtCO2 measurement was performed by a Stow-
Severinghaus sensor (tc Sensor 92 by Radiometer™,
Copenhagen, Denmark). The sensor was placed on the
earlobe heating skin to a temperature of 44°C resulting in
a dilatation of capillary bed that allows a 20 times faster
diffusion of gases (CO2 and O2) from the skin to the
sensor [12]. On the sensor, carbon dioxide reacts with
water to form carbonic acid which dissociates into H+ and
HCO3 thereby changing pH values. These pH changes
are translated into PtCO2 value through the Henderson-
Hasselbalch formula [13].
Before the study, medical and paramedical staff were
trained in the operation and maintenance of the mon-
itor PtCO2 type TCM TOSCA monitor (Radiometer™,
Copenhagen, Denmark). Patients in whom RR admis-
sion was required were included. The PtCO2 sensor was
attached to the ear lobe of the patient allowing continuous
measurement of PtCO2. Arterial blood gases and the usual
additional assessments were performed at the same time.
The medical team was blinded for the value of PtCO2.
Medical patient data were collected and computerized
after initial collection on paper case report form (CRF).
Blood pressure, heart rate and respiratory rate, blood oxy-
gen saturation, Glasgow coma scale, temperature, time
for completion of the arterial blood gases, catecholamines
use, NIV or tracheal intubation were recorded by the
attending physician. Epidemiological characteristics of
patients such as admission modalities, length of hospi-
tal stay and biological data were collected on the CRF.
PtCO2 values were automatically saved every ten seconds
by the monitor PtCO2. The primary outcome variable
was concordance between the simultaneous PaCO2 and
PtCO2 values. Sample size calculation was based on the
anticipated variation in the differences between the mea-
surements and the required precision. Using previous
study [14] for an estimate of the variation between the
differences, a sample size of 50 patients gives a precision
of ± 0.19 kPa in the limits of agreement. The secondary
outcome was to determine the factors that interfere in this
correlation.
Statistical analysis
Patient characteristics are described using qualitative
variables (using frequencies and percentages) and quan-
titative variables (using means and standard deviation or
median with interquartile depending on type of distribu-
tion). The concordance between PtCO2 and PaCO2 was
evaluated by linear regression (correlation coefficients)
and Bland-Altman analysis, which determined bias, pre-
cision, and agreement of PtCO2 and PaCO2, taking the
automated analysis in the laboratory as the reference. The
Pearson correlation coefficient was used to demonstrate
the presence or absence of a relationship between PtCO2
and PaCO2. Relationships between measurement differ-
ences (|PaCO2-PtCO2|) and patient characteristics were
investigated by regression analysis. Variables related to
the difference between PtCO2 and PaCO2 in the uni-
variable analysis (defined by p<0.10, forward selection)
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were further analysed in a multivariable model (analy-
sis of covariance). We introduced in this model PaCO2
but did not introduce pH and PtCO2 to avoid a collinear
bias. Overall model fit was assessed using the Hosmer-
Lemeshow test. All statistical tests were 2-sided. A P
value less than 0.05 was considered significant for all
analyses.
Analyses were performed with the use of R 3.0.2 (R
Core Team 2013, R: A language and environment for
statistical computing. R Foundation for Statistical Com-
puting, Vienna, Austria). The authors had full access
to and take full responsibility for the integrity of the
data.
Results
Between January 2014 and June 2014, 102 patients were
screened. Only 90 patients were analyzed with 104 PtCO2
values (Figure 1). Table 1 shows the characteristics of
the 104 measurements. After linear regression analysis of
104 couples, there was a significant correlation between
PaCO2 and PtCO2 with R2 = 0.83(P < 0.001) (Figure 2).
The linear regression equation between the two variables
was PaCO2 = 0.81 × + 10.86 PtCO2. The Bland-Altman
(12) is shown in Figure 3. The mean bias was -1.4 mm Hg
(±7.7) and limits of agreement (bias ±1.96 SD) between
the two techniques were -16.4 mm Hg and 13.7 mm Hg.
The Pearson’s correlation coefficient was 0.94 (95% CI =
0.87-0.94, P<0.001).
For group with PaC02 < 60 mmH, R2=0.70 (P<0.001)
and the mean bias was -3.5 mmHg (±5.0). For group with
PaC02> 60 mmH, R2 = 0.57 (P<0.001) and the mean bias
was 4.1 mm Hg (±10.2).
In univariate analysis, the only factor associated with a
difference between PaCO2 and PtCO2 was PaO2 (Table 2).
In multivariate analysis with three explanatory variables
(PaCO2, PaO2, temperature), we found the temperature
and the PaO2 to be significantly associated with a high
90 patients included
102 patients enrolled 




12 patients not included
6 measurements excluded
backup error
Figure 1 Flow diagram.
Table 1 Patient characteristics
Male sex, no. (%) 51 (57)
Age, mean (± SD) - year 76 (15)
Past medical history, no. (%)
Acute pulmonary edema 27 (29)
Chronic obstructive pulmonary disease 27 (29)
Ischemic heart disease 21 (23)
Home oxygen 16 (17)
Clinical data at admission, median (IQR)
Heart rate - beats/min. 94 (80-110)
Systolic blood pressure - mm Hg 122 (106-144)
Diastolic blood pressure - mm Hg 69 (60-78)
Respiratory rate - breaths/min. 24 (19-28)
Glasgow coma scale 15 (14-15)
Temperature - °C 37.0 (36.2-37.6)
Laboratory values, median (IQR)
PaCO2 - mm Hg 46.2 (37.6-66.8)
PtCO2 - mm Hg 47.2 (42.1-60.0)
PaO2 - mm Hg 73.5 (63.0-89.0)
pH 7.37 (7.30-7.43)
HCO3 - mEq/L 26.0 (22.8-29.7)
Base excess - mmol/L 1.9 (-1.9-5.8)
Lactate - mmol/L 1.3 (0.7-2.2)
Hemoglobin - g/dL 12.3 (10.9-13.8)
White blood cells - G/L 12.4 (7.9-15.5)
C-reactive protein 41 (8-122)
Glycemia - g/L 1.4 (1.2-1.7)
Brain natriuretic peptide - ng/L 1704 (579-6200)
Diagnosis, no. (%)
Heart failure 25 (27)
COPD 14 (15)
Pneumonia 42 (46)
Pulmonary embolism 5 (5)
Outcome, no. (%)
Noninvasive ventilation required 41 (45)
Intubation required 4 (4)
Admitted to hospital 61 (66)
Admitted to ICU 19 (21)
Discharged from ED 10 (11)
Death at the ED 2 (2)
Inpatient mortality 9 (10)
COPD: Chronic obstructive pulmonary disease; ED: Emergency department; ICU:
Intensive care unit; IQR: Interquartile range; PaCO2 : Partial pressure of carbon
dioxide in the blood; PtCO2 : Transcutaneous partial pressure of carbon dioxide
in the blood; PaO2 : Partial pressure of dioxygen in the blood.
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Figure 2 Linear regression between transcutaneous PtcCO2 and
PaCO2. Regression line is the continuous line, the dotted lines show
the 95% confidence interval.
difference between PaCO2 and PtCO2 (Table 2). In this
model, 11 observations were deleted because of missing
data. This model has a nonsignificant Hosmer-Lemeshow
chi-square goodness-of-fit statistic. The higher the tem-
perature of the patient, the higher the difference between
PaCO2 and PtCO2 was significant (Figure 4).
Discussion
To our knowledge, this study is the largest cohort of
PtCO2 measurements in ED. The mean bias was -1.4
Figure 3 Bland-Altman representation of comparison analysis
between PaCO2 and PtcCO2 vs means of paired measurements.
mm Hg (±7.7) and the limits of agreement (bias ±1.96
SD) between the two techniques were -16.4 mm Hg and
13.7 mm Hg. There was a significant correlation between
PaCO2 and PtCO2 (R2 = 0.83, p<0.001). This value is
comparable to what was shown in intensive care (R2 =
0.86, p<0.01) [9] while other studies have found better
correlation (R2 coefficient between 0.91 and 0.99 [15-17]).
First, this difference can be explained by the recruitment
of our patients, performed only in RR with acute respi-
ratory failure. Because a majority of our patients were
non-intubated, our results highlight the feasibility and
the potential interest of PtCO2 as EtCO2 cannot eas-
ily be monitored in non-intubated patients. Indeed, the
extreme values of PaCO2 and high PaCO2 values were
reported as possibly interfering in the correlation-PtCO2
PaCO2 [9,18-20]. Second, this difference may result from
the use of the device by a large number of doctors.
Calibration, sensor placement and latency to reach the
plateau value of PtCO2 may differ from one doctor to
another. This may lead to poorer reproducibility; some
operators use the apparatus less frequently. However, this
reflects our center daily practice and occurs when there
is any change of material. Third, our population was
more likely to have breathing disorders and therefore
agitation and/or sweating leading to mobilization of the
sensor which may disrupt the measurement. Our study
found a value PtCO2 generally greater than the value of
PaCO2 measured. Indeed, linear regression equation is
PtCO2 = 0.81 × + 10.86 PaCO2. This overestimation is in
accordance with available literature [9,21,22]. This over-
estimation may have implications for patients requiring
non-invasive ventilation and with no blood gas refer-
ence. Thus, the recommendations highlight the need to
conduct a gas analysis to verify the correlation between
the PaCO2 and PtCO2 [5]. This parameter is particularly
important to consider given that the analysis of Bland-
Altman reveals a poorer correlation values PtCO2 >60
mm Hg. The value of the mean bias reported in our study
corresponds to those found in the literature (-1.4 to 4.6
mm Hg) [15,23,24]. This dispersion of the correlation for
high values of PaCO2 was previously reported. The accu-
racy of PtCO2 seems to be restricted to patients with
PaCO2 values of <56 mm Hg [25]. One explanation for
this poor correlation with the clinical manifestations of
hypercapnia (excessive sweating and vasodilatation) lead-
ing to a lower diffusion of carbon dioxide [25]. In our
study, after multivariate analysis, only the temperature
was associated with a poor correlation between PaCO2
and PtCO2 (HR = 1.15 [0.2-2.10], p = 0.018). The notion
that the temperature can influence the correlation had
been raised by Rodriguez et al. [26]. The linear regression
analysis reveals that the higher is the body temperature,
the greater the difference between the PaCO2 and PtCO2
is important. This poor correlation can be explained by
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Table 2 Relationships betweenmeasurement differences (|PaCO2-PtCO2|) and patient characteristics, univariate and
multivariate analysis (ANCOVA)
Univariate analysis Multivariate analysis
Variable OR [95% CI] P-value OR [95% CI] P-value
Sex 1.61 [0.18-14.25] 0.66
Past medical history
Acute pulmonary edema 0.29 [0.03-2.96] 0.29
COPD 0.60 [0.06-6.18] 0.67
Ischemic heart disease 0.75 [0.06-8.91] 0.82
Home oxygen 1.01 [0.06-16.77] 0.99
Heart rate 0.98 [0.94-1.03] 0.40
Systolic blood pressure 1.01 [0.97-1.05] 0.60
Diastolic blood pressure 0.97 [0.91-1.03] 0.33
Respiratory rate 1.01 [0.88-1.18] 0.85
Temperature 2.45 [0.93-6.49] 0.07 3.01 [1.16-7.80] 0.03
PaCO2 1.05 [1.00-1.12] 0.06 1.06 [1.00-1.12] 0.05
PtCO2 1.06 [1.00-1.13] 0.06
PaO2 1.21 [1.01-1.45] 0.04 1.22 [1.02-1.47] 0.03
HCO3 0.96 [0.80-1.15] 0.64
Base excess 0.96 [0.82-1.12] 0.60
Lactate 1.44 [0.43-4.79] 0.54
Hemoglobin 1.20 [0.74-1.95] 0.45
White blood cells 0.91 [0.74-1.12] 0.38
C-reactive protein 1.00 [0.99-1.01] 0.72
Glycemia 4.70 [0.62-35.58] 0.13
Brain natriuretic peptide 1.00 [1.00-1.00] 0.82
ANCOVA: Analysis of covariance; COPD: Chronic obstructive pulmonary disease; CI: Confidence interval; PaCO2 : Partial pressure of carbon dioxide in the blood; PtCO2 :
Transcutaneous partial pressure of carbon dioxide in the blood; PaO2 : Partial pressure of dioxygen in the blood.
the fact that the higher the patient’s temperature, the
greater the difference between the temperature sensor
(44°C) is low, resulting in small changes in local perfu-
sion and thus altering the local production of CO2. This
hypothesis follows directly from the operating principle of
Figure 4 Linear regression between temperature and difference
between PaCO2 and PtCO2 (|PaCO2-PtCO2|). Regression line is the
continuous line, the dotted lines show the 95% confidence interval.
the sensor [5]. It could also be hypothesized that a high
body temperature promotes sweating and vasodilatation
making far more difficult sensor measurement. Finally,
a low blood pressure can also be a cause a poor corre-
lation [27]. This hypothesis cannot be confirmed by the
present data, has few patients has shock criteria. Similarly,
the assumption that the pH may explain poor correla-
tion [20] is not confirmed in our study in the multivariate
analysis.
Limitations
First, our study has few patients with hemodynamic insta-
bility requiring the establishment of intravenous fluids or
vasopressor support. It is therefore difficult to conclude
to any contribution from the low-speed on the correlation
between PaCO2 and PtCO2. Several studies have shown
that the correlation between the PtCO2 PaCO2 and is not
affected by the use of catecholamine but by dermal vaso-
constriction secondary to a state of shock [9,22,26]. Sec-
ondly, bodymass index (BMI) has not beenmeasured over
the study. Several studies reported conflicting conclusions
regarding the influence of the thickness of the skin, indi-
rectly estimated by BMI, on the diffusion of CO2 to the
skin and therefore the values of PcCO2 [9,22,24,25]. Third,
the majority of patients had received only blood gases
during the treatment, not for obtaining intra-individual
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correlations between different values PtCO2 and PaCO2.
This analysis was important to be able to easily predict
PaCO2 values from continuous measurement of PtCO2 in
patients requiring several hours of surveillance [26,28].
Conclusions
In patients admitted in emergency unit for acute respi-
ratory failure, there is a significant correlation between
PaCO2 and PtCO2, mainly for values below 60 mm Hg.
The two limiting factors of use are hyperthermia and users
training.
Keymessages
• In patients admitted in emergency unit for acute
respiratory failure, there is a significant correlation
between PaCO2 and PtCO2.
• This correlation is comparable to what was shown in
intensive care.
• The two limiting factors of use are hyperthermia and
users training.
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